Merz Pharms Drug Patent Portfolio
Merz Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Merz Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7638552 | Method for increasing the bioavailability of glycopyrrolate | 20 Aug, 2023 | Expired |
| US7816396 | Method for increasing the bioavailability of glycopyrrolate | 20 Aug, 2023 | Expired |
Latest Legal Activities on Merz Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Merz Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Apr, 2022 | US7816396 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Jun, 2021 | US7638552 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Apr, 2018 | US7816396 |
|
Email Notification
Critical
| 07 Dec, 2012 | US7816396 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 07 Dec, 2012 | US7638552 (Litigated) |
|
Email Notification
Critical
| 07 Dec, 2012 | US7638552 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 07 Dec, 2012 | US7816396 |
|
Correspondence Address Change
Critical
| 21 Nov, 2012 | US7638552 (Litigated) |
|
Correspondence Address Change
Critical
| 21 Nov, 2012 | US7816396 |
|
Email Notification
Critical
| 30 Aug, 2011 | US7638552 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 30 Aug, 2011 | US7638552 (Litigated) |
|
Email Notification
Critical
| 29 Aug, 2011 | US7816396 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Aug, 2011 | US7816396 |
|
Correspondence Address Change
Critical
| 26 Aug, 2011 | US7816396 |
|
Correspondence Address Change
Critical
| 26 Aug, 2011 | US7638552 (Litigated) |
Merz Pharms's Family Patents
Merz Pharms Drug List
Given below is the complete list of Merz Pharms's drugs and the patents protecting them.
1. Cuvposa
Cuvposa is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7638552 | Method for increasing the bioavailability of glycopyrrolate |
20 Aug, 2023
(1 year, 7 months ago)
| Expired |
| US7816396 | Method for increasing the bioavailability of glycopyrrolate |
20 Aug, 2023
(1 year, 7 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cuvposa's drug page